Zivo Bioscience, Inc.
ZIVO
$14.45
-$2.76-16.04%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -130.39% | -72.11% | -60.90% | -52.48% | 18.50% |
| Total Depreciation and Amortization | 8.02% | 8.02% | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -98.87% | 4.56% | -- |
| Total Other Non-Cash Items | 7,493.24% | 5,603.55% | 629.14% | 467.10% | -90.24% |
| Change in Net Operating Assets | -128.09% | -139.08% | 96.17% | -87.95% | 59.43% |
| Cash from Operations | 24.68% | 25.63% | 36.86% | 17.22% | 15.70% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -70.72% | -70.52% | -58.42% | -58.42% | 175.36% |
| Total Debt Repaid | 67.70% | 69.35% | -176.21% | -177.57% | -178.90% |
| Issuance of Common Stock | -16.35% | 31.05% | 5.03% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -16.54% | 30.57% | -39.56% | 405.42% | 26,080.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 641.34% | 183.15% | 30.30% | 99.63% | 98.91% |